Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

PDL BioPharma

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.

Redefining communications excellence

Redefining communications excellence

While biopharma companies can rely on third parties for lots of the communication creation process, their own staff typically play a central role in discussions about who the key stakeholders are

CHMP delays decision on Kiadis’ GVHD immunotherapy

CHMP delays decision on Kiadis’ GVHD immunotherapy The biopharma submitted a marketing authorisation application to the European Medicine Agency in April last year as an adjunctive treatment in HSCT for adult malignant disease.

BMS finds a new immunotherapy partner with $12m Compugen deal

BMS finds a new immunotherapy partner with $12m Compugen deal Compugen says COM701 preclinical data suggest the newly-discovered PVRIG pathway may be a dominant pathway in certain cancer subpopulations, including those that are unresponsive to PD‑ 1 or PDL-1

BMS finds a new immunotherapy partner with $12m Compugen deal

BMS finds a new immunotherapy partner with $12m Compugen deal Compugen says COM701 preclinical data suggest the newly-discovered PVRIG pathway may be a dominant pathway in certain cancer subpopulations, including those that are unresponsive to PD‑ 1 or PDL-1

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics